The importance of mitochondria in energy production has long been appreciated, but new research on the dynamic nature of mitochondria (that is, their ability to undergo continuous cycles of fission and fusion) has highlighted their role in normal cell physiology and disease. Mitochondria actively communicate and interact with each other and with other cellular organelles, such as the endoplasmic reticulum, to satisfy the cell's changing energetic needs and protect it from excessive Ca 2+ influx, oxidative damage and mitochondrial DNA (mtDNA) mutations -events that typically characterize aging and neurodegenerative processes.
Mitochondria are important organelles in all cell types, but they are particularly important in the nervous system. Mitochondrial function is essential to neuronal processes such as energy production, Ca 2+ regulation, maintenance of plasma membrane potential, protein folding by chaperones, axonal and dendritic transport and the release and re-uptake of neurotransmitters at synapses [1] [2] [3] (FIG. 1) . Mitochondria help neurons to meet the high energy demands of proper neuronal function -unlike other cell types, neurons cannot switch to glycolysis when oxidative phosphorylation becomes limited. Furthermore, mitochondrial transport, together with the dynamic processes of mitochondrial fission and fusion, facilitates the transmission of energy across long distances, which is particularly important in neurons given that axons can extend up to one metre in motor neurons. Whereas mitochondrial fission allows for mitochondrial renewal, redistribution and proliferation into synapses 2, 4 , the competing process, mitochondrial fusion, allows mitochondria to interact and communicate with each other, facilitating mitochondrial movement and distribution across long distances and to the synapses 4, 5 . As individual mitochondria are subject to injury and dysfunction, it is likely that mitochondrial fusion serves as a protective mechanism, by preventing these deficiencies from damaging the entire neuron while maintaining an adequate level of bioenergetic capacity 5, 6 . However, recent studies suggest that mitochondrial fission could also have a protective role as the segregation of damaged and inactive mitochondria facilitates autophagic clearance 7, 8 .
In the past few years, multiple findings have suggested that disruptions of mitochondrial function and dynamics contribute to neurodegenerative diseases
. Here, we focus on our current understanding of the mechanisms of mitochondrial fission and fusion, the regulation of these processes and how they can contribute to neurodegenerative disease.
Fission and fusion mechanisms
Mitochondrial fission and fusion were first described in yeast 9, 10 . Fission and fusion allow the mixing of metabolites and mtDNA, the proliferation and distribution of mitochondria and cellular adaptation to changing energy demands. A group of large GTPases mediate mitochondrial fission and fusion. Although their precise mechanism of action is unclear, the sequence homology between dynamin, a yeast GTPase that is involved in the scission of vesicles in endocytosis 11 , and these GTPases suggests potential mechanisms for mitochondrial fission and fusion. Furthermore, the conservation of these 
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GTPases across species allows us to correlate the findings from pioneering studies in yeast with the potential mechanisms of mitochondrial fission and fusion in mammalian cells.
Mitochondrial fusion requires both outer and inner mitochondrial membrane components 2 . studies in yeast identified the proteins Fzo1 and Mgm1 as key mitochondrial fusion mediators [12] [13] [14] . The mammalian orthologues of Fzo1 are mitofusin 1 (MFN1) and mitofusin 2 (MFN2), which derive from two homologous genes (Mfn1 and Mfn2). The mammalian orthologue of Mgm1 is optic atrophy 1 (oPA1). Figure 1 | neuronal mitochondria. a | Neurons contain several hundred mitochondria that form cable-like structures along neuronal projections to help the neuron meet its large energy demands. Neurons require energy to transport organelles and cargo along microtubules or actin fibres (motor molecules, such as dyneins, kinesins and myosin, mediate this process) and to maintain ion gradients and the membrane potential with ATP-dependent Ca 2+ and Na + /K + pumps and ion channels. Additionally, neurotransmitter-vesicle loading at presynaptic terminals and Ca
2+
-mediated neurotransmitter release into the synaptic cleft are also ATP-dependent events. Glutamate transporters mediate glutamate re-uptake from the synaptic cleft and, at the postsynaptic membrane, glutamate binding to NMDA (N-methyl-d-aspartate) receptors (NMDARs) evokes Ca 2+ influx, which in turn can activate nitric oxide synthase (NOS) and stimulate the generation of nitric oxide (NO). Both NO and Ca 2+ can directly modulate mitochondrial function by altering the levels of reactive oxygen species (H 2 O 2 and O 2 -) and ATP production. b | A fluorescence three-dimensional microscope image of mitochondria in a dendritic arbor of a neuron expressing DsRed-Mito, a red fluorescent fusion protein that is targeted selectively to the mitochondrial matrix. c | The top panel shows a slice through a mitochondrion in a neuronal process, as seen using electron tomography. Mitochondria are typically 2-25 µm long in neurites, with a diameter of 0.2-0.5 µm. The bottom panel shows a view of the surface-rendered volume after segmentation of the same mitochondrion. The outer membrane is a translucent pale blue and individual cristae are shown in different colours. Nature Reviews | Neuroscience Outer membrane fusion. Fzo1, MFN1 and MFN2 are large GTPases that are localized to the mitochondrial outer membrane and that direct mitochondrial fusion (FIG. 2a) . The amino-terminal region of each contains the conserved GTPase domain, and the carboxyterminal region consists of a coiled-coil structure (FIG. 2b) . Mutations in the GTPase domain or in the coiled-coil domains of Fzo1 inhibit mitochondrial fusion in yeast 15 , and in vitro studies indicated that Fzo1 interacts in trans to align mitochondrial outer membranes for fusion events 16 . In addition, MFN1 and MFN2 have been found to form homo-oligomeric and heterooligomeric complexes in trans 6, 17, 18 . It has been proposed that Fzo1, MFN1 and MFN2 mediate mitochondrial fusion by tethering outer membranes together through interactions of their coiled-coil domains in trans 18 . The crystal structure of the mitofusin homologue from cyanobacteria, bacterial dynamin-like protein (BDlP) 19 , reveals a compact molecule in which the predicted GTPase and coiled-coil domains do not form discrete entities. Instead, BDlP contains a GTPase domain (residues 68-287), a long helix-loop-helix amino terminus (residues 1-67) and a long fourhelix bundle region that forms the neck, trunk and tip of the molecule. Moreover, the two predicted transmembrane helices (residues 572-606) resemble a hydrophobic paddle that could insert into lipid bilayers to promote membrane curvature and fusion (FIG. 2b) . These findings suggest that the paddle region of MFN2 is likely to be directly involved in membrane fusion. Based on these structural observations, we propose a new model of MFN2-mediated mitochondrial fusion (FIG. 2c) . Whether additional factors assist this process remains uncertain.
Inner membrane fusion. In yeast, inner membrane fusion requires Mgm1, suggesting that the mammalian orthologue oPA1 is also involved in this process 20, 21 ( FIG. 2d) . Indeed, Opa1-mutant mice and homozygous opa1-mutant Drosophila melanogaster exhibit increased mitochondrial fragmentation [22] [23] [24] . In addition, in vitro analysis of mitochondrial fusion indicated that mitochondria that are deficient in Mgm1 can fuse their outer membranes but not their inner membranes 25 . A mitochondrial targeting sequence (MTs) at the N terminus of oPA1 and Mgm1 mediates mitochondrial import (FIG. 2e) . Adjacent to the MTs, a transmembrane helix anchors the proteins to the mitochondrial inner membrane (FIG. 2e) . Proteolytic cleavage in vivo releases both Mgm1 and oPA1 from the membrane, producing functionally distinct isoforms that are necessary for normal fusion activity (for a review see REF. 2) . studies have identified several proteases that might cleave oPA1, including PArl 26 , the i-AAA protease yMe1l 27, 28 and the human or murine m-AAA protease 29 . Interestingly, mutations in paraplegin, a member of the AAA protease family, cause an autosomal recessive form of spastic paraplegia, a peripheral neuropathy 30 . Mechanistically, like Fzo1, Mgm1 seems to interact with itself in trans through its GTPase and GeD domains to tether mitochondrial inner membranes 25 . Because of the sequence similarity between Mgm1 and oPA1, we can speculate that the mechanism of mitochondrial inner membrane fusion in mammalian cells is similar.
Box 1 | Mitochondrial dysfunction during neurodegeneration
Mitochondrial defects are observed in many common neurodegenerative diseases. Oxidative damage is an early event in human Alzheimer's disease 137 : Amyloid-β (Aβ) peptide inhibits complex IV (cIV) and thus increases the production of damaging reactive oxygen species (ROS) in mitochondria (see figure) 138, 139 . Inhibitors of complex I (cI), such as rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), cause parkinsonism 140, 141 . Moreover, proteins that are mutated in familial forms of Parkinson's disease (PD), including leucine-rich repeat kinase 2 (LRRK2), α-synuclein (α-Syn), parkin, DJ1 and PTEN-induced putative kinase 1 (PINK1), associate with the mitochondrial outer membrane (OM) and are involved in ROS production or defence. HTRA2 (also known as OMI), another protein that is mutated in familial PD, localizes to the intermembrane space (IMS) of mitochondria and might be involved in proteolytic processing of mitochondrial proteins 84 . Familial amyotrophic lateral sclerosis (FALS) is characterized by defects in Ca 2+ loading 142 , suggesting that the mutant protein in FALS, superoxide dismutase 1 (mtSOD1), might disrupt Ca 2+ channels. In addition, mtSOD1 might block protein import at the mitochondrial OM 143 , disrupt the respiratory chain and cause aberrant ROS production 144 , and block the anti-apoptotic actions of BCL2 (REF. 145 ). Mouse models of Huntington's disease (HD) exhibit early defects in respiration and ATP production 146 . Interestingly, 3-nitroproprionic acid (3-NP) is a mitochondrial complex II (cII) inhibitor that produces HD-like symptoms, and mutant huntingtin (mtHTT) itself seems to disrupt cII activity 147 . mtHTT also disrupts mitochondrial Ca 2+ buffering 148 . The fact that mutations in the mitochondrial fission and fusion machinery can cause neurodegenerative diseases, and the fact that the familial PD-specific genes, PINK1 and parkin, seem to play a part in mitochondrial fission 149, 150 , underscores the role of these proteins in mitochondrial health and neuronal function. Whether defective mitochondrial fission and fusion contribute to the mitochondrial dysfunction that is characteristic of neurological diseases with unknown aetiology, and whether the mutant proteins that are associated with hereditary neurodegenerative diseases cause mitochondrial dysfunction by affecting mitochondrial dynamics, are currently subjects of intensive research. Cyt c, cytochome c; IM, inner membrane; mtDNA, mitochondrial DNA. Mitochondrial fission. Dynamin 1 (Dnm1) in yeast and its mammalian homologue dynamin-related protein 1 (DrP1) cluster into large foci at the sites of mitochondrial fission 13, [31] [32] [33] [34] (FIG. 3a) . Mitochondrial fission produces spherical mitochondria and induces significant ultrastructural changes, including cristae remodelling that is characterized by fragmentation, occasional cristae dilation or vesiculation, and the disappearance of cristae membranes (FIG. 3b-e ). Dnm1 and DrP1 have three conserved domains -an N-terminal GTPase domain, a central helical domain and a GTP effector domain (GeD) -which contribute to mitochondrial fission (FIG. 3f) .
In yeast, Fis1, a small molecule that is localized to the mitochondrial outer membrane, targets cytosolic Dnm1 to the mitochondrial membrane through an indirect interaction [35] [36] [37] [38] . The role of the mammalian homologue of Fis1, hFIs1, in recruitment of DrP1 to the mitochondria is less clear, because DrP1 cycling in and out of contact with mitochondria does not require hFIs1 (REFS 39,40); however, hFIs1 silencing inhibited fission, suggesting that hFIs1 acts downstream of DrP1 recruitment 40 . studies in yeast favour a model in which Dnm1 selfassembles into spirals and localizes to mitochondrial membrane constriction sites -characterized by the accumulation of Dnm1 oligomers as large foci or belts around mitochondria and by a reduction in mitochondrial diameter from ~0.5 µm to 0.1 µm -through an indirect interaction (involving Mdv1 and Caf4) with Fis1. When it is bound to analogues of GTP that cannot be hydrolysed to GDP, Dnm1 assembles into ring and spiral-like structures 41 . Mutations that impair GTP binding prevent spiral formation and mitochondrial fission 33, 34 . Interestingly, the addition of hydrolysable GTP causes the disassembly of the highly ordered rings and spirals 41 . Thus, GTP hydrolysis by Dnm1, which is required for fission but not for the assembly of oligomeric complexes, might cause a conformational change in the protein that helps to complete the fission event 41 .
In mammals the mechanism is likely to be similar, with hFIs1, and potentially other proteins such as 
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ganglioside-induced differentiation associated protein 1 (GDAP1) 42 , interacting with DrP1 to mediate the conversion of DrP1 into an active, fission-promoting conformation 2 .
Regulation of fission and fusion Cells continually adjust the rate of mitochondrial fission and fusion in response to changing energy demands and to facilitate the distribution of mitochondria 43 . recent studies have identified three post-translational modifications that seem to regulate mitochondrial fission and fusion proteins: phosphorylation, sumoylation and ubiquitylation.
Protein kinase A (PKA) phosphorylates DrP1 at ser637 in the variable domain of humans and at ser656 in the conserved GeD of rats 44, 45 . This phosphorylation has been shown to cause a significant decrease in GTPase activity 44 and to inhibit mitochondrial fission 44, 45 . Interestingly, another study found that mitosispromoting factor (MPF, also known as cyclin-dependent kinase 1 (CDK1)/cyclin B) phosphorylates DrP1 at ser585 in rats during mitosis 46 . unlike phosphorylation by PKA, CDK1/cyclin B phosphorylation seems to stimulate mitochondrial fission during mitosis 46 . Thus, it seems that phosphorylation of DrP1 by different kinases at different amino acids has opposite effects. Finally, cyclin-dependent kinase 5 (CDK5) is another key regulator of mitochondrial fission 47 . Whether CDK5 phosphorylates DrP1 or other proteins that are involved in mitochondrial fission, such as components of the cytoskeleton, remains unclear. Additionally, whether kinases that have been implicated in Parkinson's disease (PD) pathogenesis, such as leucine-rich-repeat kinase 2 (lrrK2) and PTeN-induced putative kinase 1 (PINK1), regulate DrP1 or other related factors remains a question for future investigation.
sumoylation is another means of DrP1 regulation. small ubiquitin-related modifier 1 (suMo1) interacts with DrP1 and associates with mitochondria at fission sites before and after fission 48 . Time-lapse microscopy showed that DrP1 and suMo1 initially localize to the middle of the mitochondrion and then after fission remain localized on the tip of one of the divided mitochondria 48 . overexpression of suMo1 leads to mitochondrial fragmentation and apoptosis, probably because suMo1 protects DrP1 from degradation, stabilizes the DrP1 pool and enhances DrP1 binding to mitochondria 40, 48 . ubiquitylation has also been associated with mitochondrial dynamics. several studies have identified a mitochondrial outer membrane protein, membraneassociated rING-CHv (MArCH-v or MArCH5), that ubiquitylates DrP1, but the effect of MArCH5 on mitochondrial dynamics remains unclear [49] [50] [51] . Cells that express MArCH5 mutants and MArCH5 interfering rNA (rNAi) exhibit cable-like mitochondria with varying degrees of thickness 49 . These findings suggest that MArCH5 might ubiquitylate DrP1 to promote fission or ubiquitylate and deactivate an unknown repressor of fission 49 . These findings contradict two earlier studies that found that MArCH5 ubiquitylation of DrP1 produced abnormal, elongated mitochondria 50, 51 . These differences could be a result of using different imaging techniques and/or criteria for evaluating mitochondrial morphology.
In summary, although phosphorylation, sumoylation and ubiquitylation seem to be important processes in the regulation of mitochondrial fission and fusion, the pathways and proteins that are involved are far from clear. Further research on the modulation of mitochondrial dynamics in human disease is necessary.
Mitochondrial fission and cell death
Programmed cell death is an important process in both health and disease 39, 52 . Although mitochondrial fission is an early event in cell death, the precise role of fission in cell death remains unclear. expression of the dominant-negative DrP1 mutant, DrP1 K38A , in cell lines decreases mitochondrial fragmentation and blocks cell death in response to staurosporine, gamma radiation and etoposide 52, 53 . In addition, downregulation of hFIs1 inhibited Hela cell death 39 , inhibition of DrP1 partially protected Caenorhabditis elegans cells against cell death 54 , inhibition of DrP1 reduced and delayed mitochondrial fragmentation and cell death in embryonic D. melanogaster cells 55, 56 , and inactivation of DrP1 by phosphorylation protected PC12 cells from various apoptotic insults 45 . Finally, a fungal-aging model indicates that deletion of the dnm1 gene extends lifespan and delays apoptosis 57 . The discovery that BAx and BAK, two proapoptotic regulators, interact with mitochondrial fission and fusion GTPases further supports the functional link between mitochondrial dynamics and apoptosis. BAx forms large foci with DrP1 and MFN2 on mitochondria during apoptosis 53 , and hyperglycaemic injury of dorsal root ganglion cells causes DrP1 and BAx to associate 58 . Furthermore, neurons challenged with toxic levels of nitric oxide (No) exhibit BAx foci on mitochondria as they undergo mitochondrial fission. Inhibiting DrP1 function delays mitochondrial fission, BAx foci formation and neuron loss 7, 59 . BAK also seems to have a crucial function in mitochondrial dynamics during apoptosis, as it complexes with MFN1 and MFN2 (REFS 60, 61) .
Despite the strong correlation between mitochondrial fission and cell death, some studies have questioned the importance of mitochondrial fission and fragmentation in apoptosis. For example, inhibition of hFIs1 and DrP1 prevents mitochondrial fragmentation but does not block apoptosis [62] [63] [64] . Conversely, hFIs1 and DrP1 might be able to promote apoptosis without causing fission 40, 65 . Thus, the pro-apoptotic and fission-promoting functions of hFIs1 and DrP1 might be distinct, and mitochondrial fragmentation per se might not cause apoptosis. supporting this hypothesis, cells that were deficient in both hFIs1 and oPA1 exhibited fragmented mitochondria, similar to oPA1-rNAi cells, but were resistant to apoptosis, similar to hFIs1-rNAi cells 39 .
Attempting to correlate studies in cell lines with neurodegeneration is difficult. First, it is reasonable to assume that neurons, which are post-mitotic, behave differently from actively dividing cells. second, classical caspase-dependent apoptosis does not adequately account for the slow onset and progression of neurodegenerative diseases. It is possible that mitochondrial fission contributes to chronic neurodegeneration through other non-apoptotic cell-death pathways, such as type II and type III programmed cell death -autophagic or 'necrosis-like' pathways that are caspase-independent 7, 66, 67 . Alternatively, it is possible that persistent mitochondrial fission could lead to cell dysfunction (including synaptic damage 68 and bioenergetic failure 7 ) and subsequent neurodegeneration, rather than cell death.
Mitochondrial dynamics and bioenergetics
Because mitochondria provide most of the energy that is necessary to maintain neuronal function, it is important to consider the possible link between changes in mitochondrial dynamics and bioenergetic failure. Nitrosativestress-induced mitochondrial fission in cultured neurons results in bioenergetic defects, neuronal dysfunction and cell death 7 . similarly, blocking DrP1 activity with rNAi in Hela cells prevented mitochondrial fission and decreased respiratory activity and ATP production 69 . Interestingly, a lack of mitochondrial fusion per se causes bioenergetic defects in cultured non-neuronal cells 20 : cells that lack both MFN1 and MFN2, which have mitochondria that are unable to fuse, have significant bioenergetic defects 20 . In addition, cells that lack either MFN1 or MFN2 or that overexpress oPA1 exhibit fragmented mitochondria but are not bioenergetically defective 20 . Thus, it seems that a lack of fusion factors might cause bioenergetic defects independently of changes in mitochondrial morphology. Intriguingly, there seems to be a bidirectional relationship between mitochondrial fragmentation and bioenergetics, as a decrease in ATP can also stimulate fragmentation 69 . Thus, although there is convincing evidence that disruption of mitochondrial dynamics and bioenergetic defects are closely linked, the precise relationship remains unclear. Further supporting the idea of there being multiple roles for mitochondrial fission and fusion proteins in bioenergetics, another study found that translocation of DrP1 to mitochondria can cause a decrease in respiration in a GTP-independent process in normal and leukaemic B lymphocytes 66 . This suggests that DrP1 might also function in two distinct ways: first, as a mediator of mitochondrial fission, through a GTP-dependent mechanism; and second, as an inhibitor of mitochondrial function and possible mediator of Type III programmed cell death, through a GTP-independent mechanism.
To summarize, although it is becoming clear that proteins that direct mitochondrial fission and fusion can contribute to bioenergetic failure under certain conditions, the precise role of mitochondrial dynamics requires further investigation.
Fission-and fusion-protein mutations loss-of-function mutations in the genes that encode mitochondrial fusion GTPases cause neurodegenerative disease 70 . Mutations in MFN2 cause Charcot-MarieTooth (CMT) subtype 2A (CMT2A), a peripheral neuropathy that is characterized by muscle weakness and axonal degradation of sensory and motor neurons 71, 72 , and hereditary motor and sensory neuropathy type vI (HMsN vI), which is clinically similar to CMT but also involves optic atrophy and visual impairment 73 . Mutations in OPA1 cause the most common form of optic atrophy, autosomal dominant optic atrophy (ADoA). Patients with ADoA exhibit progressive loss of vision and degeneration of the optic nerve and retinal ganglion cells 74 . In addition, some mutations in the oPA1 GTPase domain cause ' ADoA-plus' phenotypes that are also characterized by deafness, sensory-motor neuropathy and musclemovement disorders 75, 76 . The similarity of the symptoms caused by Mfn2 and OPA1 mutations supports the idea that these proteins are functionally linked.
A recent study characterized nine MFN2 mutants that are associated with CMT2A 77 , five of which cannot induce mitochondrial fusion. The ability of the other four MFN2 mutants to fuse mitochondria suggests that MFN2 has other roles, not related to fusion, in disease pathology. one study suggests that MFN2 might have a role in mitochondrial trafficking, and that disruption of this function could lead to peripheral axon degeneration 4 . Additionally, the non-functional MFN2 mutants promoted mitochondrial fusion in Mfn2-null cells but not in Mfn1-null cells 77 , suggesting that MFN1 complementation, possibly resulting from heteromeric associations 6 , can rescue mitochondrial fusion. These results might also explain why mutations in Mfn2, despite being present in all cells, only affect specific neurons in CMT2A: cells with limited MFN1 activity, which are therefore less able to compensate for the Mfn2 mutations, might be more susceptible 77 . Whether the levels of MFN1 are indeed reduced in degenerating neurons in patients with CMT2A is an important question for future study.
The current mitochondrial fusion hypothesis states that MFN2 and oPA1 are mechano-enzymes that use GTP hydrolysis to switch between distinct conformations that facilitate membrane fusion 78, 79 . Intriguingly, most of the missense mutations that are found in Mfn2 in patients with CMT and in OPA1 in patients with ADoA reside in the highly conserved GTPase domains (FIG. 4) and, thus, could interfere with nucleotide binding and hydrolysis. However, a number of missense mutations are also located outside the GTPase domain (for example, Mfn2 W740s (FIG. 4a) and OPA1 l939P (FIG. 4c) ), pointing to critical residues that will be valuable starting points for further dissecting the mechanisms by which these molecules recognize and fuse mitochondrial membranes.
A recent case study reported a dominant-negative mutation in the part of the human DRP1 gene that encodes the helical domain 80 . The patient exhibited elongated and tangled mitochondria that were concentrated around the nucleus, a feature that is characteristic of impaired mitochondrial fission 80 . unfortunately, the patient died 37 days after birth, displaying some symptoms that were similar to those of ADoA and CMT2A. obviously the DrP1-related disease had a much earlier onset, and the impact of the DRP1 mutations was much more severe than those of the fusion mutations. Nature Reviews | Neuroscience 
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Finally, mutations in the gene that encodes GDAP1, which localizes to the outer membrane and seems to participate in DrP1-dependent mitochondrial fission 42 , cause CMT4A, another subtype of CMT syndrome [81] [82] [83] . CMT4A combines demyelination with axon loss, and the homozygous GDAP1 mutation causes early onset and more severe progression 83 .
Mitochondrial fission and sporadic disease
Mitochondrial dysfunction is a characteristic of many neurodegenerative disorders, but is mitochondrial fission activated in, or causally related to, sporadic neurodegenerative disease? If so, what might activate this pathological mitochondrial fission? several triggers might contribute to this cell-specific shift in the balance between fission and fusion, including oxidative stress and altered regulation by cell-cycle kinases.
Oxidative stress. Because mitochondria are the primary producers of reactive oxygen species (ros), oxidative damage of mitochondrial proteins or DNA is likely to contribute to the mitochondrial dysfunction that is characteristic of many neurodegenerative diseases 84 . However, another potential deleterious effect of increased ros levels is chronic mitochondrial fission. Nitrosative stress causes profound mitochondrial fission in neurons before the onset of neuron loss in an animal model of stroke 7 , and treatment with antioxidants has been shown to reduce mitochondrial fission. expression of MFNs or dominant-negative DrP1 partially prevented mitochondrial fission and neuron death by No, which is known to be largely caspase-independent. Another study found that oxidative stress promoted mitochondrial fission in cerebellar granule neurons, and that MFN2 expression was protective 85 . Whether oxidative stress directly regulates the mitochondrial fission and fusion GTPases is currently unclear.
Cell-cycle kinases in neurodegeneration.
A growing body of research suggests that cyclin-dependent kinases (CDKs), many of which are important regulators of the cell-cycle, have a key role in neuron death 86 . Multiple in vitro models of neuron death indicate that activation of CDKs is a required step in the cell-death cascade [86] [87] [88] . In addition, studies have found increased levels of CDK4 in ischaemic brain tissue and mouse models of amyotrophic lateral sclerosis (Als) 89, 90 , increased levels of CDK2 and CDK4 in post-mortem brain samples from Alzheimer's Disease (AD) patients 91 , and increased CDK5 activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) models of PD 92 . Furthermore, genetic studies have linked certain polymorphisms of CDK1 with increased susceptibility to AD 93, 94 . As mentioned above, CDK1 can phosphorylate DrP1, increase its activity and stimulate mitochondrial fragmentation 46 . Although this process is likely to serve a functional role in cell division, aberrant activation of CDK1 in post-mitotic neurons could cause deleterious mitochondrial fragmentation, neuronal dysfunction and cell death. It is also known that neuronal mitochondria favour different morphologies at different time points in their life cycle. Immature neurons have smaller, less-connected mitochondria, whereas mature, highly functional neurons have elongated, connected mitochondria 95 . Keeping this in mind, it is conceivable that factors that induce mitochondrial fission in mature neurons could cause energy depletion, neuronal dysfunction and eventual neuronal demise. such a mechanism of neuronal dysfunction would help to explain the late onset and progressive nature of many neurodegenerative diseases, such as AD.
Mitochondrial dynamics and onset of disease Mitochondrial diseases caused by hereditary mtDNA mutations and diseases that are associated with mitochondrial dysfunction have unique characteristics that are hard to explain: they affect only specific cell types and, despite the mutations being present from birth, they show delayed onset. The emerging roles of mitochondrial fission and fusion, including synaptic maintenance, bioenergetics and genetic drift of mtDNA subpopulations, along with an increased appreciation of differences in the mitochondrial proteome in different cell types, might shed light on these properties.
Synaptic maintenance. synaptic function and maintenance are crucial for neuronal survival and efficient cell-to-cell communication. Mitochondria are highly relevant to synaptic maintenance because synapses have high energy requirements 96 . In addition, the synaptic micro-environment is highly dynamic: it is awash with ions and neurotransmitters that move in and out of the synaptic cleft. Mitochondria buffer Ca 2+ ions, which modulate action-potential firing and the release of neurotransmitter-containing vesicles (FIG. 1a) .
A decline in mitochondrial activity at synapses might be among the earliest events in neurodegenerative diseases, initiating clinical symptoms such as memory loss and cognitive decline 97 . studies also indicate that mitochondrial fission and fusion are necessary for synaptic maintenance. First, DrP1 overexpression in hippocampal neurons from rat embryos promoted synaptogenesis, whereas oPA1 and mutant DrP1 overexpression had the opposite effect, probably because of differences in mitochondrial distribution 68 . Both DrP1 and oPA1 overexpression cause mitochondrial fragmentation, yet they have the opposite effect on synaptogenesis and function. What could account for this apparent contradiction? oPA1 exists in multiple proteolytically processed isoforms, and both the short and the long isoforms are necessary for mitochondrial fusion. Thus, oPA1 overexpression could overwhelm the system with too much of either the long or the short isoform, irreversibly blocking fusion. Conversely, DrP1 overexpression stimulates fission, but fusion can still occur. This creates the perfect situation for synaptic maintenance, as mitochondria can fuse, which helps them to reach the synapse 4 , and actively divide, which is crucial for proliferation into the synapse 68, 98 . Further supporting the role of mitochondrial fission in synaptic health, the cellsurvival protein BCl-x l increases synapse number and function by stimulating DrP1's GTPase activity (and thus DrP1-mediated fission) in cultured
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hippocampal neurons 99 ; furthermore, in D. melanogaster a Drp1 mutation prevented the mobilization of the neurotransmitter reserve pool 100 . These findings suggest a mechanism that might explain why mutations in fission and/or fusion proteins only affect specific types of cells in hereditary neurodegenerative diseases (for example, ADoA and CMT2A) and, potentially, why specific types of neurons selectively degenerate in sporadic neurodegenerative diseases.
Selection and accumulation of mtDNA mutations. The mtDNA genome is small (16.5 kb in mammals) and codes for only 13 proteins in humans 101 , but its integrity is important for proper mitochondrial function, and mutations or loss of mtDNA can damage cells 102, 103 . Mutations in mtDNA can cause aging [104] [105] [106] [107] , which is the leading risk factor for neurodegenerative disease.
The potential role of mitochondrial fusion in the expansion of mtDNA deletion mutants is controversial. A modelling study of mitochondrial fusion and the proliferation of mtDNA mutations, in which fusion was assumed to occur regularly and create a shared compartment of mtDNA and structural components, found that the size of mtDNA deletions increases with age 108 . The authors of this study suggested that, whereas the wild-type mtDNA maintains mitochondrial function and keeps the mitochondria viable, smaller, mutated mtDNAs (that is, those with larger deletions) might have a survival advantage because they might replicate more rapidly 109, 110 . strikingly, the model produced a deletion-mutant profile that was remarkably similar to an experimental rat profile 108 . However, the relevance of this model to the physiological situation in postmitotic neurons is unclear because it relies on the proposed selective advantage of faster replication of small mtDNA mutants, which might be of relevance only to actively dividing cells. In addition, other models have proposed that random drift can account for the clonal expansion of mtDNA mutants that occurs with age 111 . Another study of Purkinje cells that had impaired mitochondrial fusion suggested that a lack of fusion might cause a loss of mtDNA 5 . MFN2-deficient Purkinje cells seemed to exhibit a greater number of mitochondria that completely lacked mtDNA compared with wild-type cells, although this study lacked quantitative analysis and requires further confirmation 5 . As is the case with mtDNA deletion mutants, a lack of fusion might cause the proliferation of mtDNA-deficient mitochondria by preventing the mixing and exchange of mitochondrial components. A loss of mitochondrial fusion could, over time, allow a build up of mitochondria that lack mtDNA. Although this would not be initially harmful, at some point the cell would become defective because there would not be enough viable mitochondria for efficient respiration and energy production.
Two new studies indicate that oPA1 has an important role in mtDNA stability and maintenance 75, 76 . Mutations in the oPA1 GTPase domain, known as 'oPA1-plus' mutations, result in increased breakage or truncation of mtDNA molecules. These new findings suggest an mtDNA-stabilizing function for oPA1 in addition to its established role in mitochondrial fusion. Because both oPA1 and nucleoids (the structural units of mtDNA that consist of five to seven copies of mtDNA and multiple mitochondrial proteins) associate closely with the mitochondrial inner membrane, it is conceivable that oPA1 mutations could disrupt the nucleoids and promote mtDNA mutations 23, [112] [113] [114] . Although mitochondrial fusion probably protects cells from mtDNA loss and point mutations, it might also promote the accumulation of mtDNA mutants with larger deletions. Thus, the precise relationship between mitochondrial fusion and mtDNA mutations is complicated and requires further investigation. upregulation of mitochondrial fusion could have both positive and negative effects on overall health. In addition, the activity of fusion proteins such as oPA1, as opposed to mitochondrial fusion per se, might be important for mtDNA maintenance because these proteins probably have multiple functions.
Cell-type-specific mitochondrial fission. one of the more mysterious characteristics of neurodegenerative mitochondrial disease is the cell-type-specific pathogenesis. Compared with other cell types, neurons seem to be particularly vulnerable to changes in mitochondrial morphology and connectivity, probably owing to their large energy requirements and unique energy-transmission demands. But why can some neurons survive whereas others cannot? Proteomic studies indicate that mitochondrial gene-expression profiles are tissue-specific 94, 115 . These findings suggest that neuronal mitochondria in different areas of the brain have different properties and might respond to stressors, such as ros, increased mitochondrial fission and genetic mutations, more or less efficiently.
Is mitochondrial fission reversible?
If mitochondrial fission and fusion contribute to neurodegeneration and aging, it is necessary to consider whether they offer new opportunities for therapy. Three avenues that warrant further examination are transcriptional regulation of mitochondrial biogenesis, exercise and ros management.
What can compensate for too much fission? Because too much mitochondrial fission negatively affects mitochondrial function, stimulating mitochondrial biogenesis could compensate for the deleterious effects. Peroxisome proliferator-activated receptor-g co-activator-1α (PGC1α) is a transcriptional co-activator that is a master regulator of mitochondrial biogenesis and respiration 116, 117 . PGC1α regulates the expression of many mitochondrial genes, including those that are associated with mitochondrial biogenesis and antioxidant defence 116 . Thus, increased expression of PGC1α in degenerating neurons suffering from excessive mitochondrial fission might be neuroprotective and a potential therapeutic option. There is considerable evidence that PGC1α has a neuroprotective function [117] [118] [119] . Nature Reviews | Neuroscience
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Exercise and mtDNA mutations. exercise is a wellestablished tool in the fight against aging and age-related diseases, such as neurodegenerative disease. For example, voluntary exercise in mice increases neurogenesis in the hippocampus 120, 121 and increases metabolic capacity in the motor cortex 122 . Does exercise improve mitochondrial function? A large body of research indicates that it does. First, exercise improves energy metabolism by stimulating mitochondrial biogenesis 123 and increasing the expression of PGC1α 124, 125 . Mitochondrial biogenesis is important because it increases the amount of wild-type mtDNA, and the loss of wild-type mtDNA in mutant cells is a major cause of respiratory defects 126 . In addition, resistance exercise reverses many aspects of the aging transcriptome in skeletal muscle, increasing the expression of many proteins that are related to mitochondrial function 127 . Finally, expression of MFN1 and MFN2 increases 24 hours after endurance exercise 128 , and increased levels of MFN2 in developing muscle tissue correlates with more efficient mitochondrial function and energy transmission frm the cell periphery to the cell core 129 . Thus, exercise has a significant impact on mitochondrial function. The relationship between exercise, nutrition, metabolism and mitochondrial fission and fusion is less clear but is a subject of increasing interest.
Another area of interest is the relationship between exercise and mtDNA mutations. Accumulation of mutations in mtDNA with age is one mechanism of mitochondrial dysfunction. An early case study showed that resistance exercise training produced an increase in wild-type, non-mutant mtDNA in a mitochondrial myopathy patient who carried a mutation in more than 90% of his skeletal muscle mtDNA 130 . The decrease in mutant mtDNA probably results from gene shifting -the fusion of mitochondria and the transfer of mtDNA from wild-type satellite cells that lack the mutation to mitochondria from mutant cells (FIG. 5) . Does resistance exercise induce gene shifting and a decrease in mtDNA mutations in healthy older adults? A study of healthy older adults found no decrease in mtDNA mutations following resistance exercise 131 . However, exercise could provide functional benefits by decreasing the mutant mtDNA load in key areas to below a pathological threshold, through fusionmediated redistribution of mtDNA mutations within cells or tissues, while increasing or failing to decrease the total occurrence of mtDNA mutations 132, 133 . Thus, the potential of exercise to revert mutations in mtDNA through a fusion-related pathway is certainly of great interest and deserves further research. The applicability of these lines of research in muscle cells to mitochondrial dysfunction in neurodegenerative disease is also an open question.
ROS management.
Because ros are an important cause and effect of increased mitochondrial fission, effective ros management might be crucial in the fight against fission damage. Nitrosative stress induces mitochondrial fission that is often asymmetric, with one daughter mitochondrion retaining a normal ultrastructure and the other exhibiting significant damage 7 . This stressinduced fission in immature neurons and neurons expressing survival molecules, such as BCl-x l , was frequently reversible (e.B.-W., unpublished observations). Thus, transitory fission induced by oxidative stress could increase cell survival by allowing the excision and degradation of damaged mitochondria by an autophagic process. However, if the oxidative stress persists, resulting in chronic and persistent fission, a shift to cell death might occur. It is likely that differential signal-transduction pathways determine whether mitochondrial-fissionmediated cell survival or cell death predominates.
In addition to their role in ros production, mitochondria also have an extensive ros-defence system that neutralizes ros and includes coenzyme Q10, cytochrome c, glutathione, manganese superoxide dismutase, catalase and glutathione peroxidase 84 . ros induce PGC1α activity, which increases the expression of the ros-detoxifying enzymes 134, 135 and protects neurons from oxidative stress 117 . Although ros-directed therapies for neurodegenerative disease are conceptually appealing, their therapeutic viability is questionable. Clinical antioxidant trials have been largely ineffective in treating neurodegenerative disease. This comes as no surprise. The ros system is highly complex, consisting of different types of compounds with different properties and functions. In addition, it stands to reason that beginning antioxidant treatment after disease onset probably cannot undo the damage that has been done by years of oxidative stress. At best it could slow progression, which is a positive outcome but far from a cure. Finally, we must also consider the negative effects of antioxidant therapy, which could include disruption of the beneficial roles of ros (for example, cell signalling and the induction of mitochondrial-fission-mediated cell survival) and desensitization of the native ros-defence mechanisms 84 . PGC1α treatments could hold greater promise, because of the potential for more widespread effects. PGC1α can enhance the native ros-defence system and stimulate mitochondrial biogenesis. However, overexpression of PGC1α in mice causes cardiac abnormalities 136 , suggesting a potential problem for the use of PGC1α treatments in humans. In addition, the same basic flaw that applies to antioxidant therapies also applies to potential PGC1α therapies. such strategies are strictly responsive and do not target the underlying cause of the problem. even if oxidative stress causes mitochondrial dysfunction in neurodegenerative diseases, we must improve our understanding of what happens earlier in the disease process to cause increased ros production. only then will we be able to intervene early enough in the pathogenic cascade to provide anything more than temporary relief.
Outlook
Because of their important role in energy production, mitochondria are vital to health maintenance throughout the aging process. It is becoming increasingly clear that mitochondrial dysfunction leads to neurodegeneration and aging. The dynamic nature of mitochondria, characterized by tightly controlled fission and fusion, is an important part of mitochondrial health and function. In addition, there is a growing appreciation of the range of effects that mitochondrial fission and fusion events have in cells and of the proteins that are involved in these processes. Fission and fusion might also have an important role in processes such as the modulation of bioenergetics and the complementation of mtDNA mutations. Furthermore, fission and fusion proteins, beyond maintaining mitochondrial morphology, probably contribute to other cellular processes, such as cell death and development. We are just beginning to understand the importance of mitochondrial fission and fusion to aging and neurodegeneration, and continued research into mitochondrial dynamics, focusing on both the big picture and the individual players, will enhance our understanding of mitochondrial health and hopefully lead to breakthroughs in the diagnosis, treatment and prevention of a wide variety of neurodegenerative diseases.
